Furthermore, downregulation of RPS7 has been shown to promote the migration of tumour cells in ovarian37 and prostate38 cancers through representative PI3K/AKT and MAPK cancer signalling pathways and EMT, respectively. Here, RPS7 is linked to neoplasm.